Catalyst Wire Dossier Catalyst Wire Dossier

SHR8028 eye drops

· Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR8028 eye drops, covering 2023-05-03 to 2023-05-03. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease [Phase 3]

See pricing